Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer

被引：1
|
作者：
Bolla, M. [1 ]
Fourneret, P. [1 ]
Descotes, J. -L. [2 ]
机构：
[1] CHU, Clin Univ Cancerol Radiotherapie, F-63011 Grenoble, France
[2] CHU, Clin Univ Urol, F-63011 Grenoble, France
来源：
BULLETIN DU CANCER | 2008年 / 95卷 / 12期
关键词：
high-risk prostate cancer; combination of external irradiation and androgen suppression;
D O I：
10.1684/bdc.2008.0755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Treatment of high-risk prostate cancer-localized or locally advanced-is based on the combination of external irradiation and hormonal treatment by LHRH analogue (aLHRH) according to the results of phases III randomized trials RTOG and/or EORTC trials. These trials show a significant improvement of overall or specific survival. Localized prostate cancer require 6-month complete androgen blockade, while locally advanced prostate cancer need a long-term hormonal treatment for a duration ranging from 2,5 to 3 years. Some trials, which have a long follow-up show that the risk of cardiovascular death is not significantly increased by hormonal treatment.
引用
收藏
页码：1213 / 1218
页数：6
相关论文
共 50 条
  • [1] Association of radiotherapy and hormonotherapy in locally advanced prostate cancer
    Quero, Laurent
    Wong-Hee-Kam, Stephanie
    Rivera, Sofia
    Hennequin, Christophe
    [J]. BULLETIN DU CANCER, 2012, 99 : S30 - S36
  • [2] Radiotherapy for high-risk prostate cancer
    Jahan J. Mohiuddin
    Brock R. Baker
    Ronald C. Chen
    [J]. Nature Reviews Urology, 2015, 12 : 145 - 154
  • [3] Radiotherapy for high-risk prostate cancer
    Mohiuddin, Jahan J.
    Baker, Brock R.
    Chen, Ronald C.
    [J]. NATURE REVIEWS UROLOGY, 2015, 12 (03) : 145 - 154
  • [4] Postprostatectomy radiotherapy for high-risk prostate cancer
    Mayer, R
    Pummer, K
    Quehenberger, F
    Mayer, E
    Fink, L
    Hackl, A
    [J]. UROLOGY, 2002, 59 (05) : 732 - 739
  • [5] Management of high-risk prostate cancer: surgery or radiotherapy with hormonal treatment
    Soulie, M.
    Richaud, P.
    [J]. ONCOLOGIE, 2012, 14 (02) : 79 - 86
  • [6] Pelvic proton radiotherapy for high-risk prostate cancer
    Chera, B. S.
    Vargas, C.
    Flampouri, S.
    Morris, C. G.
    Yeung, D.
    Olivier, K.
    Duvvuri, S.
    Li, Z.
    Mendenhall, N. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S326 - S326
  • [7] Use and timing of radiotherapy in high-risk prostate cancer
    Ward, JF
    Blute, ML
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (23): : 2817 - 2817
  • [8] Radiotherapy after prostatectomy in high-risk prostate cancer
    Roviello, G.
    Villari, D.
    Nesi, G.
    Detti, B.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (11): : 2139 - 2140
  • [9] Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer
    Garcia Hernandez, Trinitat
    Vicedo Gonzalez, Aurora
    Pastor Peidro, Jorge
    Rosella Ferrando, Juan V.
    Brualla Gonzalez, Luis
    Granero Cabanero, Domingo
    Lopez Torrecilla, Jose
    [J]. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (05) : 265 - 271
  • [10] Is surgery superior to radiotherapy for high-risk prostate cancer?
    Eastham, James A.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 438 - 438
12345